載入...
Glucose Control and Cardiovascular Outcomes in Clinical Trials of Sodium Glucose Co-transporter 2 Inhibitor Treatments in Type 2 Diabetes
Currently available medications for the treatment of type 2 diabetes have limitations, and many patients do not achieve glycaemic control. Recently, a new approach has emerged using sodium glucose co-transporter 2 (SGLT2) inhibitors that decrease glucose reabsorption in the kidneys, increasing urina...
Na minha lista:
| 發表在: | Eur Endocrinol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Touch Medical Media
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5983080/ https://ncbi.nlm.nih.gov/pubmed/29872475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17925/EE.2014.10.02.117 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|